Anti-CD33 antibodies, anti-CD33/anti-CD3 bispecific antibodies and uses thereof | Patent Number 11466082

US 11466082 B2
Application Number16418420
Publication NumberUS 20190382481 A1
Pendency3 years, 4 months, 24 days
Filled DateMay 21, 2019
Priority DateMay 24, 2018
Publication DateDec 19, 2019
Expiration DateMay 23, 2038
Inventor/ApplicantsFrancois Gaudet
Michael Diem
Ronan McDaid
Priyanka Nair-Gupta
ExaminesBRISTOL, LYNN ANNE
Art Unit1643
Technology Center1600
Assignments
Janssen Biotech Inc.
Current
Janssen Biotech Inc.Johnson & Johnson
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.